Xylitol

Xylitol

SCHEMBL18429950

CC(O)CO.OC[C@@H](O)[C@H](O)[C@@H](O)CO

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Xylitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.67
LMNA P02545 4/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
KDM4E B2RXH2 2/20 0.48
PDE4A P27815 1/20 0.42
TSHR P16473 3/20 0.41
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
ALDH1A1 P00352 3/20 0.37
TOP1 P11387 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adonitol SCHEMBL27608468 1.00 TDP1 (0.67) TDP1LMNAL3MBTL1KDM4EPDE4A
Mannitol SCHEMBL21327681 0.93 LMNA (0.73) TDP1LMNAL3MBTL1KDM4EPDE4A
Sorbitol SCHEMBL1605233 0.93 LMNA (0.73) TDP1LMNAL3MBTL1KDM4EPDE4A
Mannitol SCHEMBL5050555 0.93 LMNA (0.73) TDP1LMNAL3MBTL1KDM4EPDE4A
Adonitol SCHEMBL28031758 0.86 LMNA (0.71) TDP1LMNAL3MBTL1KDM4EPDE4A
E968 SCHEMBL18493349 0.86 TDP1 (0.77) TDP1LMNAL3MBTL1KDM4EPDE4A
Xylitol SCHEMBL6240620 0.86 LMNA (0.71) TDP1LMNAL3MBTL1KDM4EPDE4A
Xylitol SCHEMBL4599492 0.86 LMNA (0.83) TDP1LMNAL3MBTL1KDM4EPDE4A
Xylitol SCHEMBL5273838 0.86 LMNA (0.83) TDP1LMNAL3MBTL1KDM4EPDE4A
Xylitol SCHEMBL8749454 0.86 LMNA (0.83) TDP1LMNAL3MBTL1KDM4EPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3132789-B1 COSMETIC DOW TORAY CO LTD (JP) 2024-01-17 EP disclosed
US-10130579-B2 Cosmetic material DOW CORNING TORAY CO., LTD. (JP) 2018-11-20 US disclosed
EP-3132789-A1 COSMETIC Dow Corning Toray Co., Ltd. (JP) 2017-02-22 EP disclosed
US-20170035681-A1 COSMETIC MATERIAL DOW TORAY CO., LTD. (JP) 2017-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10130579-B2 Cosmetic material CUTA, H1-0, TRPA1 TDP1 4105/4885LMNA 983/4885L3MBTL1 2330/4885
US-20170035681-A1 COSMETIC MATERIAL CUTA, H1-0, TRPA1 TDP1 4105/4885LMNA 983/4885L3MBTL1 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.